Stockscreener 앱 받기
42.98
3.57%
-1.59
시간 외 거래:
43.18
0.20
+0.47%
전일 마감가:
$44.57
열려 있는:
$44.44
하루 거래량:
16.74M
Relative Volume:
0.44
시가총액:
$9.35B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
62.29
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-4.70%
1개월 성능:
-25.45%
6개월 성능:
+7.83%
1년 성능:
+156.90%
1일 변동 폭
$42.97
$44.83
1주일 범위
$40.93
$45.71
52주 변동 폭
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
42.98 | 10.19B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
156.15 | 364.75B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
62.08 | 150.27B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.05 | 68.10B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
130.75 | 43.57B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.19 | 40.49B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Lost Money on Hims & Hers Health, Inc. (HIMS)? Contact Levi & Korsinsky to Join Class Action Before August 25, 2025 - Newsfile
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to ActHagens Berman - GlobeNewswire
Deadline Approaching for Investors of Hims & Hers Health, Inc. (HIMS)Contact Kaplan Fox Before August 25, 2025 - FinancialContent
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd - GlobeNewswire
Commit To Purchase Hims & Hers Health At $25, Earn 27.8% Using Options - Nasdaq
HIMS Investors Have the Opportunity to Lead the Hims & Hers - GlobeNewswire
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained - ACCESS Newswire
Here's How I Am Buying Hims & Hers At $37 Or Earning 4.2% Monthly Instead (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
Hims & Hers Health (NYSE:HIMS) Shares Down 5% Following Analyst Downgrade - Defense World
Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook - MSN
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
Shareholders that lost money on Hims & Hers Health, - GlobeNewswire
Why Hims & Hers Health (HIMS) Stock Is Falling Today - Yahoo Finance
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your RightsHIMS - NewMediaWire
What's Going On With Hims & Hers Shares Today?Hims & Hers Health (NYSE:HIMS) - Benzinga
Investors in Hims & Hers Health, Inc. (HIMS): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - Stockhouse
HIMS Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Soaring Legal Troubles Rock Hims & Hers Health (HIMS) - timothysykes.com
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals - TradingView
Class Action Filed Against Hims & Hers Health, Inc. (HIMS)August 25, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Hims & Hers Health Stock Falls While GoodRx Rallies on Deal with Novo Nordisk - TipRanks
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - Morningstar
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
GDRX stock soars 30% today: GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims - Fast Company
Hims & Hers: Navigating a Perfect Storm of Regulatory and Partnership Risks in the Telehealth Era - AInvest
Meta's reported shake-up, Hims & Hers sinks on GoodRx–Novo deal - Yahoo Finance
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers (HIMS) Drops Amid Reported Details of FTC - GlobeNewswire
Levi & Korsinsky Releases SueWallSt Podcast on Hims & Hers Health, Inc. (HIMS) Lawsuit - ACCESS Newswire
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationHIMS - Morningstar
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Hims & Hers Health, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsHIMS - 富途牛牛
Hims & Hers Health Under Investigation for Securities Fraud Violations - AInvest
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
Hims & Hers Health: Legal Storms and the Future of Shareholder Value - AInvest
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline Reminder in Hims & Hers Health, Inc. Securities Class Action Lawsuit - Morningstar
Join Class Action to Recover Losses from Hims & Hers Health, Inc. (HIMS)Contact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. InvestorsLead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - The Malaysian Reserve
HIMS IMPORTANT DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, - GlobeNewswire
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hims Hers Health Inc 주식 (HIMS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dudum Andrew | Chief Executive Officer |
Aug 18 '25 |
Option Exercise |
2.43 |
125,335 |
304,564 |
197,855 |
| Dudum Andrew | Chief Executive Officer |
Aug 18 '25 |
Sale |
45.06 |
128,127 |
5,773,242 |
89,521 |
| Dudum Andrew | Chief Executive Officer |
Aug 18 '25 |
Sale |
45.05 |
47,534 |
2,141,492 |
142,592 |
3.57%
자본화:
|
볼륨(24시간):